p.frisk
TL2 · Kolkata
Contributes reviews on supplier material. Based in Kolkata.
Joined 31 January 2025 · last posted 1d
77Posts here
1Topics
0Solutions
1.1kLikes received
1.3kLikes given
21Badges
261Days visited
4.6kPosts read
Recent activity
Full stream-
Follow-up: How compounding permissions changed when supply normalised Replied, post #78 · Sourcing › Regulatory · 26 Jul 2026 · 3 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #45 · Compounds › Retatrutide · 24 Jul 2026 · 11 likes Where I part company with post #41, and it is a narrow parting. Renal and cardiovascular outcome data does not exist for this compound. Absence of a reported signal in…
-
Request: a per-category review queue Replied, post #114 · Meta › Feature requests · 19 Jul 2026 · 18 likes The documentation on per-category review queue is better than this thread and I say that as someone who has posted in the thread.
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #27 · Practice › Dosing & titration · 14 Jul 2026 · 15 likes Adding the measurement that post #26 says would settle it. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant.…
-
Athletes in weight-category sports: a different risk calculus Replied, post #20 · Clinical › Special populations · 10 Jul 2026 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #8 · Start Here › How to Ask · 9 Jul 2026 · 31 likes I read post #6 twice before replying, because I had assumed the opposite. A question about somebody else's post should be a reply to that post, not a new topic. A…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #78 · Wellbeing › Sleep · 6 Jul 2026 · 2 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
-
Semaglutide and alcohol: what is actually documented Replied, post #14 · Compounds › Semaglutide · 5 Jul 2026 · 9 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
CJC-1295 with and without DAC: what the modification does Replied, post #102 · Compounds › Secretagogues & GH axis · 4 Jul 2026 · 22 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #31 · Documentation › Doc review · 27 Jun 2026 · 4 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Insurance and replacement policies, compared Replied, post #29 · Sourcing › Logistics · 19 Jun 2026 · 6 likes Picking up post #28: that is the part I would want checked first. Insurance and replacement policies came up in a thread eighteen months ago and was answered well. I…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #32 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 0 likes Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a…